Genetics, a healthtech start-up co-founded by three University of Cambridge genomics postgraduates, has raised USD11 million in a Series A funding round led by MMC Ventures, with further funding from Episode 1, Seedcamp and several angel investors. These include Paul Forster, a co-founder and former CEO of Indeed, Paul Wicks, former VP of innovation at PatientsLikeMe, and Margo Georgiadis, the former CEO of Ancestry.com.   The startup has developed a software platform that connects patients living with rare and chronic conditions, such as Long Covid, multiple sclerosis, Parkinson’s and Alzheimer’s, directly with biotech and pharma companies leading personalised medicine research

Intermediate Capital Group (ICG), a global alternative asset manager, has completed fundraising for its debut Infrastructure fund, ICG Infrastructure Equity 1 (ICG Infra), with total commitments of EUR1.5 billion, surpassing its target of EUR1 billion due to strong demand from a global client base. The Fund attracted commitments from over 40 clients across Europe, the UK, Australia, the US and Canada. The Fund focuses on Western Europe and is pursuing a green generalist strategy aligned to UN Sustainable Development Goals. To date, the team has deployed EUR1 billion across five deals, of which the Fund has committed EUR0.6 billion and

Gresham House Ventures, a growth equity investor specialising in software and digitally driven businesses in the consumer, healthcare and services sectors, has invested GBP5 million in retailtech specialist Proximity Insight (PI). Using the PI app, retail teams can instantly get to know each customer through their profile, displaying their preferences, trends, and purchase history. Equipped with customer knowledge, retail teams can then use PI’s full functionality to communicate, serve, and transact with customers all from a single tool. This complete end-to-end, omni-channel functionality is what makes the Proximity Insight app “super” for retailers, providing them with an enormous competitive advantage,

OnePlanetCapital has invested in eco-friendly e-Bike conversion kit company Swytch through its flagship Environmental EIS Fund. Swytch has raised a total of GBP3.1 million at a GBP35 million pre money valuation.   The OnePlanetCapital EIS fund focuses on companies and projects that will genuinely benefit the environmental prospects of the UK and the wider planet, supporting the emerging green economy. Investing into the eBike company Swytch will support the overall negative impact in busy urban environments that are being challenged.   Swytch comes is creating a product that is easy to set up and can be used on 99 per

Ørsted has signed an agreement to divest a 50 per cent ownership stake in its 1.3 GW Hornsea 2 Offshore Wind Farm in the UK to a consortium comprising AXA IM Alts, acting on behalf of clients, and Crédit Agricole Assurances. Hornsea 2 is currently under construction and will become the world’s largest offshore wind farm once commissioned later in 2022. The total value of the transaction is GBP 3.0 billion, and the transaction is expected to close in the second half of 2022 once the wind farm is fully commissioned and customary regulatory approvals are obtained.   AXA IM

Main Capital Partners (Main) has launched an international software group that specialises in solutions for Governance, Risk and Compliance (GRC) processes. This strategic development comes after the acquisition of a majority stake in Swedish Blika Solutions (Blika) and the immediate addition of audimex in Germany as its first add-on portfolio company. The financial details for these transactions have not been disclosed.   Blika, headquartered in Stockholm, represents the first Nordic platform investment from the Main Foundation I fund, which was launched in October 2021 targeting innovative, high-growth software companies. 

Main will support the Group with further strengthening its position in

Cakesmiths, an independent manufacturer and supplier of artisan handmade cakes, has secured investment from leading mid-market private equity firm and cake afficionado LDC to support the next stage of its growth journey. Bristol-based Cakesmiths supplies its range to a number of independent customers across the UK through its direct-to-market online platform.   The business caters to a wide range of palates, including a broad vegan and very-low gluten range – plus it prides itself on exciting innovation and limited edition ‘small batch’ runs. Eight products received Great Taste Awards in 2021, including Billionaire’s Shortbread, Persian Love Loaf and Ultimate Carrot

Funds managed by KKR and Global Infrastructure Partners (GIP) have completed their acquisition CyrusOne in an all-cash transaction valued at approximately USD15 billion, including the assumption of debt. Trading of the company’s shares of common stock has been suspended on the NASDAQ Global Select Market (“Nasdaq”), and that CyrusOne has requested that its common stock be delisted from Nasdaq. Intention to voluntarily delist its 1.450 per cent Senior Notes due 2027 (the “Notes”), as well as to deregister the Notes from registration with the Securities and Exchange Commission.

Investcorp, a global manager of alternative investment products, has sold its majority stake in Agromillora (“the Company”) to the founders of Agromillora and to Edify, the investment holding company controlled by the Despature family. The financial terms of the transaction have not been disclosed.   Founded in Barcelona in 1986, Agromillora is a provider of advanced plant propagation services to the agricultural industry with a focus on permanent crop producing trees including stone fruit trees, citrus trees, almond and other nut trees, olive trees, berries and vines.    Investcorp invested in Agromillora in December 2016 and has worked closely with

Global investment firms PAI Partners and Carlyle are to acquire Theramex, a global specialty pharmaceuticals company focused on women’s health, from CVC Capital Partners VI (CVC). Theramex was created following the carve-out of a portfolio of women’s health pharma products in 2018, and has subsequently developed into one of the largest specialty pharma platforms dedicated to women and their health. The company provides patient-focused solutions across contraception, fertility, menopause, and osteoporosis with the aim of providing patients with products that can support them through their life journey.  With the support of Carlyle and PAI Partners, Theramex will seek to expand